Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535307) titled 'Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes' on April 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Novo Nordisk A/S
Condition:
Diabetes Mellitus
Intervention:
Drug: NNC0487-0111
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 10, 2026
Target Sample Size: 80
Countries of Recruitment:
Germany
To know more, visit https://clinicaltrials.gov/study/N...